Background Sentinel lymph node biopsy (SLNB), an acceptable alternative to axillary lymph
node dissection for staging patients with breast cancer, was introduced to clinical practice in …

Background Sentinel lymph node biopsy (SLNB) has become the preferred method for
axillary nodal staging. The authors examined SLNB utilization in urban versus rural settings …

To evaluate differences in use of sentinel lymph node biopsy (SLNB) by age and race in
Medicare recipients with early-stage breast cancer, we examined Surveillance …

Sentinel lymph node biopsy (SLNB) in breast cancer has not been readily adopted into
Canadian surgical practice in comparison with the United States. We sought to evaluate …

Background Sentinel lymph node biopsy (SLNB) has become a standard for axillary staging
for early breast cancer patients. Prior studies suggest that SLNB may be more sensitive for …

Importance Sentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in
patients with clinically node-negative breast cancer. It is not known whether SLNB rates …

Background: Ongoing clinical trials are addressing the accuracy and safety of sentinel node
biopsy (SNB) in the treatment of breast cancer; however, SNB is already increasingly being …

Background: Several surgeon characteristics are associated with the use of sentinel lymph
node biopsy (SLNB) for breast cancer. No studies have systematically examined the relative …

BACKGROUND: We sought to determine whether the results of sentinel lymph node (SLN)
biopsy are related to practice and community factors. METHODS: This prospective study …

BACKGROUND There are no data available from randomized controlled trials that compare
the efficacy of sentinel lymph node (SLN) biopsy with Level I/II axillary lymph node …